Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Moritz Bewarder, MD, Gerhard Held, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Gabi Carbon, Birgit Bette, Konstantinos Christofyllakis, MD, Arne Felbel, Dominic Kaddu-Mulindwa, MD, Niels Murawski, MD, Stephan Stilgenbauer, Frank Neumann, PhD

Blood (2019) 134 (Supplement_1): 5616.

https://doi.org/10.1182/blood-2019-126998

Published: 2019

Journal Articles

CTX-8573, an Innate-Cell Engager Targeting BCMA, is a Highly Potent Multispecific Antibody for the Treatment of Multiple Myeloma

Blood (2019) 134 (Supplement_1): 3182.

https://doi.org/10.1182/blood-2019-128749

Published: 2019

Journal Articles

Drug-Free Macromolecular Therapeutics Induce Apoptosis in Cells Isolated from Patients with B Cell Malignancies with Enhanced Apoptosis Induction By Pretreatment with Gemcitabine

Jiawei Wang, Lian Li, PhD, Jiyuan Yang, PhD, Phillip M. Clair, MS, Martha Glenn, MD, Deborah M. Stephens, D. Christopher Radford, PhDCandidate, Ken M. Kosak, Michael W. Deininger, MD PhD, Paul J Shami, MD, Jindřich Kopeček, PhD

Blood (2018) 132 (Supplement 1): 4426.

https://doi.org/10.1182/blood-2018-99-112001

Published: 2018

Journal Articles

Mitochondrial Fission Protein Drp1 Regulates Megakaryocyte and Platelet Mitochondrial Morphology, Platelet Numbers, and Platelet Function

Emilia A Tugolukova, Robert A. Campbell, PhD, Kelly B Hoerger, Hansjorg Schwertz, MD, Andrew S. Weyrich, PhD, Jesse W Rowley, PhD

Blood (2017) 130 (Supplement 1): 455.

https://doi.org/10.1182/blood.V130.Suppl_1.455.455

Published: 2017

Journal Articles

Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens

Christian M. Seitz, MD, Patrick Schlegel, MD, Jana Hau, Ann-Christin Krahl, Sarah Schroeder, Giulia Bender, Selina Reiter, Sabine Schleicher, PhD, Karin Schilbach, PhD, Martin Ebinger, MD, Philipp Knopf, MSc, Manfred Kneilling, MD, Bernd J. Pichler, PhD, Joerg Mittelstaet, PhD, Dominik Lock, MSc, Andrew Kaiser, PhD, Peter J. Lang, MD, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 1912.

https://doi.org/10.1182/blood.V130.Suppl_1.1912.1912

Published: 2017

Journal Articles

Lung Vaso-Occlusion in Sickle Cell Disease Mediated By Arteriolar Neutrophil-Platelet Micro-Emboli

Margaret F. Bennewitz, PhD, Ravi Vats, MS, Egemen Tutuncuoglu, MS, Mark T. Gladwin, MD, Prithu Sundd, PhD

Blood (2016) 128 (22): 159.

https://doi.org/10.1182/blood.V128.22.159.159

Published: 2016

Journal Articles

Intravenous Immunoglobulin (IVIg) Is a Highly Effective Treatment for HIT: Critical Role of the IgG Fc Domain in Inhibiting HIT Antibody-Mediated Platelet Activation

Anand Padmanabhan, MBBS, MA, PhD, Curtis G Jones, Shannon M Pechauer, Barbara J. Bryant, MD, Jack B. Alperin, MD, Mehraboon S. Irani, MBBChir, Binod Dhakal, MDMS, Brian R Curtis, PhD D(ABMLI) MT(ASCP)SBB, Daniel W. Bougie, PhD, Mia J Sullivan, Renren Wen, PhD, Demin Wang, PhD, Richard H. Aster, MD

Blood (2016) 128 (22): 2600.

https://doi.org/10.1182/blood.V128.22.2600.2600

Published: 2016

Journal Articles

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Jawed Fareed, PhD, Larissa Reikensmeyer, Amanda Walborn, BS, Debra Hoppensteadt, PhD, Jeanine M. Walenga, PhD, Eduardo Ramacciotti, MD, Schuharazad Abro, MD, Walter Jeske, PhD, Olivia Bouchard, Ismail Elalamy, MD PhD

Blood (2016) 128 (22): 3836.

https://doi.org/10.1182/blood.V128.22.3836.3836

Published: 2016

Journal Articles

Origin of (sporadic) Plasma Cell Myeloma: Lysolipids Are Not the Target of Clonal Immunoglobulins

Michael Pfreundschuh, MD, PhD, Natalie Fadle, Evi Regitz, Maria Kemele, Klaus-Dieter Preuss, PhD

Blood (2016) 128 (22): 2055.

https://doi.org/10.1182/blood.V128.22.2055.2055

Published: 2016

Journal Articles

Binding of Quinine-Dependent Monoclonal Antibodies to Gpiib/Iiia Appears to Involve Drug-Induced Modulation of Antibody Affinity

Daniel W. Bougie, PhD, Julie A. Peterson, PhD, Mark Rasmussen, Richard H. Aster, MD

Blood (2015) 126 (23): 2246.

https://doi.org/10.1182/blood.V126.23.2246.2246

Published: 2015

Journal Articles

Induction of NK and T Cell Immune Responses Against Leukemia Cells By Bispecific NKG2D-CD16 and -CD3 Fusion Proteins

Samuel Koerner, Lothar Kanz, MD, Ludger Grosse-Hovest, Gundram Jung, Helmut R Salih, MD

Blood (2015) 126 (23): 2558.

https://doi.org/10.1182/blood.V126.23.2558.2558

Published: 2015

Journal Articles

Platelet Desialylation: A Novel Mechanism of Fc-Independent Platelet Clearance and a Potential Diagnostic Biomarker and Therapeutic Target in immune Thrombocytopenia

June Li, MSc, Dianne Evertdina van der Wal, PhD, Guangheng Zhu, MD, Miao Xu, MSc, MD, Issaka Yougbare, PhD, Li Ma, PhD, Brian Vadasz, BSc, Renata Grozovsky, PhD, Min Ruan, MD, Lingyan Zhu, MD, Qingshu Zeng, MD, Lili Tao, MD, Zhi-min Zhai, MD, Jun Peng, MD, Ming Hou, MD, Valery Leytin, PhD, John J. Freedman, MD, Karin M Hoffmeister, MD, Heyu Ni, MD PhD

Blood (2014) 124 (21): 467.

https://doi.org/10.1182/blood.V124.21.467.467

Published: 2014

Journal Articles

Synthetic Anti-IL3 Receptor Antibodies As Therapeutics to Block Innate Imatinib Resistance in Chronic Myelogenous Leukemia

Mahsa Abrishami, MSc, Landon Pastushok, PhD, Karen Mochoruk, MLT, John F. DeCoteau, MD, C. Ronald Geyer, PhD

Blood (2014) 124 (21): 4519.

https://doi.org/10.1182/blood.V124.21.4519.4519

Published: 2014

Journal Articles

Assessing Structure-Activity Relationships in FVIII By Integration of Structural, Biophysical, and Biochemical Data Obtained with Anti-FVIII Antibodies

Zhiqian Lucy Liu, PhD, George Bou-Assaf, PhD, Ming Zhang, PhD, Allison Goodman, Po-lin Chiu, PhD, Melissa Chambers, Thomas Walz, PhD, Robert Peters, PhD, John Kulman, PhD

Blood (2014) 124 (21): 4223.

https://doi.org/10.1182/blood.V124.21.4223.4223

Published: 2014

Journal Articles

Evidence For Flexible Tethering Of Fc To FVIII In Recombinant FVIII-Fc Fusion Protein rFVIIIFc

Nina Leksa, Ph.D., Lucy Liu, Ph.D., Allison Goodman, Po-lin Chiu, Ph.D., Thomas Walz, Ph.D., Robert Peters, Ph.D., John Kulman, Ph.D.

Blood (2013) 122 (21): 1102.

https://doi.org/10.1182/blood.V122.21.1102.1102

Published: 2013

Journal Articles

Imaging Morphologic Changes On Platelet and Monocyte Surfaces In Heparin-Induced Thrombocytopenia (HIT)

Lubica Rauova, MD, PhD, Yanjun Zhang, PhD, Vincent M. Hayes, Chandrasekaran Nagaswami, Douglas B. Cines, MD, Jing-fei Dong, MD, PhD, Mortimer Poncz, MD, John W. Weisel, PhD.

Blood (2013) 122 (21): 3533.

https://doi.org/10.1182/blood.V122.21.3533.3533

Published: 2013

Journal Articles

Bispecific Hexavalant Antibodies With Enhanced Trogocytosis For Treatment Of Lupus

Edmund A Rossi, Ph.D, Rosana Michel, M.S., Chien-Hsing Chang, Ph.D, David M Goldenberg, ScD, MD

Blood (2013) 122 (21): 2282.

https://doi.org/10.1182/blood.V122.21.2282.2282

Published: 2013

Journal Articles

Rapid and Effective Isolation Of (T) Cell Populations By a New Method Avoiding Magnetic Beads

Herbert Stadler, Sabine Przibilla, Stefan Dreher, Christian Stemberger, Lothar Germeroth, Dirk Busch

Blood (2013) 122 (21): 4830.

https://doi.org/10.1182/blood.V122.21.4830.4830

Published: 2013

Journal Articles

Enhancement Of Endothelial Cell Barrier Function By Antibody-Driven Affinity Modulation Of PECAM-1

Heng Mei, M.D., Ph.D., Cathy Paddock, Jay Campbell, PhD, Ralph Albrecht, PhD, Peter J. Newman, PhD

Blood (2013) 122 (21): 193.

https://doi.org/10.1182/blood.V122.21.193.193

Published: 2013

Journal Articles

Specific Inhibition Of Ectodomain Shedding Of GPIba By Targeting Its Shedding Cleavage Site

Xin Liang, PhD, Susan R. Russell, Sandra Estelle, Limei H. Jones, Sungyun Cho, Mark L. Kahn, MD, Michael C. Berndt, PhD, Silvia T. Bunting, Jerry Ware, PhD, Renhao Li, PhD

Blood (2013) 122 (21): 21.

https://doi.org/10.1182/blood.V122.21.21.21

Published: 2013

NARROW

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

CTX-8573, an Innate-Cell Engager Targeting BCMA, is a Highly Potent Multispecific Antibody for the Treatment of Multiple Myeloma

Drug-Free Macromolecular Therapeutics Induce Apoptosis in Cells Isolated from Patients with B Cell Malignancies with Enhanced Apoptosis Induction By Pretreatment with Gemcitabine

Mitochondrial Fission Protein Drp1 Regulates Megakaryocyte and Platelet Mitochondrial Morphology, Platelet Numbers, and Platelet Function

Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens

Lung Vaso-Occlusion in Sickle Cell Disease Mediated By Arteriolar Neutrophil-Platelet Micro-Emboli

Intravenous Immunoglobulin (IVIg) Is a Highly Effective Treatment for HIT: Critical Role of the IgG Fc Domain in Inhibiting HIT Antibody-Mediated Platelet Activation

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Origin of (sporadic) Plasma Cell Myeloma: Lysolipids Are Not the Target of Clonal Immunoglobulins

Binding of Quinine-Dependent Monoclonal Antibodies to Gpiib/Iiia Appears to Involve Drug-Induced Modulation of Antibody Affinity

Induction of NK and T Cell Immune Responses Against Leukemia Cells By Bispecific NKG2D-CD16 and -CD3 Fusion Proteins

Platelet Desialylation: A Novel Mechanism of Fc-Independent Platelet Clearance and a Potential Diagnostic Biomarker and Therapeutic Target in immune Thrombocytopenia

Synthetic Anti-IL3 Receptor Antibodies As Therapeutics to Block Innate Imatinib Resistance in Chronic Myelogenous Leukemia

Assessing Structure-Activity Relationships in FVIII By Integration of Structural, Biophysical, and Biochemical Data Obtained with Anti-FVIII Antibodies

Evidence For Flexible Tethering Of Fc To FVIII In Recombinant FVIII-Fc Fusion Protein rFVIIIFc

Imaging Morphologic Changes On Platelet and Monocyte Surfaces In Heparin-Induced Thrombocytopenia (HIT)

Bispecific Hexavalant Antibodies With Enhanced Trogocytosis For Treatment Of Lupus

Rapid and Effective Isolation Of (T) Cell Populations By a New Method Avoiding Magnetic Beads

Enhancement Of Endothelial Cell Barrier Function By Antibody-Driven Affinity Modulation Of PECAM-1

Specific Inhibition Of Ectodomain Shedding Of GPIba By Targeting Its Shedding Cleavage Site

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only